198HO02045 CAMIRAP *RC

Print/PDF
Registration Name CHEMELLO CAMIRAP RF-ET
Registration Number HOITA024990486030
Primary NAAB Code 198HO02045
Secondary Code(s)
Status Inactive
Controller Name INTERMIZOO S.p.A. (198)
Date of Birth 1/15/2015
aAa 324165
DMS -
GFI 7.3%
Genetic Codes * TL TV TY RC TC TM
Haplotypes HH1T, HH2T, HH3T, HH4T, HH5T, HH6T, HHR-C
Sire GO-FARM RAPTOWN-ET
MGS RI-VAL-RE 2338 NIAGRA-ET
Beta Casein A1A2
Kappa Casein AB
Beta Lactoglobulin AB
INDEXES
NM$ -251, 81% R CM$ -226
NM Percentile 11% FM$ -307
GTPI 2147 GM$ -326
PRODUCTION TRAITS
540 Dtrs 181 herds 0 % US 90% R
Milk -917 Fat, % -12 , +0.10%
SCS 2.86, 90% R Protein, % -12 , +0.07%
Feed Saved -79 , 50% R Milking Speed 6.91 , 59% R
Health & Fertility
Productive Life -1.3      86% R Mastitis 1.5      73% R
Heifer Livability 0.7       49% R Metritis -1.3      67% R
Livability -0.5      80% R D. Abom 0.1      71% R
DPR -3.5      86% R Ketosis -0.2      67% R
FSC -11.4      77% R R. Placenta -1.1      68% R
HCR -3.8      80% R Milk Fever -0.1      59% R
CCR -4.1      86% R
SCR -        -
DIA 1.1      39% R
RSP 1.2      42% R
Calving Traits
Sire CE 1.8      39% R 211 Obs
Daughter CE 2.3      33% R 0 Obs, 327 Dtrs
Sire SB 3.8      33% R 651 Obs
Daughter SB 5.5      41% R 0 Obs, Dtrs
Gestation Length -0.2      76% R 0 Obs, 0 Dtrs
Early First Calving -4.4      74% R 0 Obs, 0 Dtrs

CDCB August 2026; Base of Evaluation: HO

* Individual bull owners may test for more recessives

Composites HA 08/2026
252 Dtrs 129 herds 73% R
PTA Type -0.06 UDC -0.32
HCC -0.53 BWC 0.71
FLC -0.23
Linear Traits
Stature 0.50
Tall
Strength 0.76
Strong
Body Depth 0.23
Deep
Dairy Form -0.21
Closed
Rump Angle -2.07
Flat
Thurl Width -0.39
Flat
Rear Legs-Side View -0.39
Narrow
Rear Legs-Rear View -0.10
H.-in
Foot Angle -0.30
Low
Feet & Legs Score -0.08
Low
F.U. Attachment -0.50
Straight
Rear Udder Height -0.41
Low
Rear Udder Width -0.65
Narrow
Udder Cleft -0.88
Weak
Udder Depth -0.10
H.-in
Front Teat Placement -1.49
Wide
Rear Teat Placement -2.51
Wide
Teat Length -0.39
Short
-2
0
2

CDCB August 2026; Base of Evaluation: HO